KRIZONE-S Injection is a combination antibiotic containing
Ceftriaxone, a third-generation cephalosporin antibiotic,
and Sulbactam, a beta-lactamase inhibitor. Ceftriaxone acts
by inhibiting bacterial cell wall synthesis, leading to bacterial death,
while Sulbactam prevents the breakdown of Ceftriaxone by beta-lactamase
enzymes produced by resistant bacteria. This combination enhances the
antibacterial spectrum and effectiveness against resistant organisms.